nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefpodoxime—Cefdinir—MPO—urinary bladder cancer	0.00293	0.502	CrCbGaD
Cefpodoxime—Cefaclor—MPO—urinary bladder cancer	0.0029	0.498	CrCbGaD
Cefpodoxime—Vomiting—Thiotepa—urinary bladder cancer	0.000729	0.000733	CcSEcCtD
Cefpodoxime—Pneumonia—Epirubicin—urinary bladder cancer	0.000728	0.000733	CcSEcCtD
Cefpodoxime—Rash—Thiotepa—urinary bladder cancer	0.000723	0.000727	CcSEcCtD
Cefpodoxime—Bronchitis—Doxorubicin—urinary bladder cancer	0.000723	0.000727	CcSEcCtD
Cefpodoxime—Dermatitis—Thiotepa—urinary bladder cancer	0.000722	0.000727	CcSEcCtD
Cefpodoxime—Agranulocytosis—Methotrexate—urinary bladder cancer	0.000722	0.000726	CcSEcCtD
Cefpodoxime—Headache—Thiotepa—urinary bladder cancer	0.000718	0.000723	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Epirubicin—urinary bladder cancer	0.000718	0.000722	CcSEcCtD
Cefpodoxime—Decreased appetite—Etoposide—urinary bladder cancer	0.000716	0.00072	CcSEcCtD
Cefpodoxime—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000714	0.000718	CcSEcCtD
Cefpodoxime—Renal failure—Epirubicin—urinary bladder cancer	0.000712	0.000716	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000711	0.000715	CcSEcCtD
Cefpodoxime—Body temperature increased—Cisplatin—urinary bladder cancer	0.000711	0.000715	CcSEcCtD
Cefpodoxime—Fatigue—Etoposide—urinary bladder cancer	0.00071	0.000714	CcSEcCtD
Cefpodoxime—Stomatitis—Epirubicin—urinary bladder cancer	0.000706	0.00071	CcSEcCtD
Cefpodoxime—Constipation—Etoposide—urinary bladder cancer	0.000704	0.000709	CcSEcCtD
Cefpodoxime—Pain—Etoposide—urinary bladder cancer	0.000704	0.000709	CcSEcCtD
Cefpodoxime—Neutropenia—Doxorubicin—urinary bladder cancer	0.000703	0.000707	CcSEcCtD
Cefpodoxime—Dysuria—Doxorubicin—urinary bladder cancer	0.000703	0.000707	CcSEcCtD
Cefpodoxime—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000699	0.000703	CcSEcCtD
Cefpodoxime—Haemoglobin—Methotrexate—urinary bladder cancer	0.000698	0.000702	CcSEcCtD
Cefpodoxime—Haemorrhage—Methotrexate—urinary bladder cancer	0.000695	0.000699	CcSEcCtD
Cefpodoxime—Pollakiuria—Doxorubicin—urinary bladder cancer	0.000694	0.000698	CcSEcCtD
Cefpodoxime—Asthenia—Gemcitabine—urinary bladder cancer	0.000692	0.000696	CcSEcCtD
Cefpodoxime—Haematuria—Epirubicin—urinary bladder cancer	0.00069	0.000694	CcSEcCtD
Cefpodoxime—Photosensitivity reaction—Doxorubicin—urinary bladder cancer	0.000686	0.00069	CcSEcCtD
Cefpodoxime—Weight increased—Doxorubicin—urinary bladder cancer	0.000684	0.000688	CcSEcCtD
Cefpodoxime—Epistaxis—Epirubicin—urinary bladder cancer	0.000683	0.000687	CcSEcCtD
Cefpodoxime—Pruritus—Gemcitabine—urinary bladder cancer	0.000683	0.000687	CcSEcCtD
Cefpodoxime—Nausea—Thiotepa—urinary bladder cancer	0.000681	0.000685	CcSEcCtD
Cefpodoxime—Sinusitis—Epirubicin—urinary bladder cancer	0.000679	0.000683	CcSEcCtD
Cefpodoxime—Feeling abnormal—Etoposide—urinary bladder cancer	0.000679	0.000683	CcSEcCtD
Cefpodoxime—Hyperglycaemia—Doxorubicin—urinary bladder cancer	0.000678	0.000682	CcSEcCtD
Cefpodoxime—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000676	0.00068	CcSEcCtD
Cefpodoxime—Pneumonia—Doxorubicin—urinary bladder cancer	0.000674	0.000678	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000674	0.000678	CcSEcCtD
Cefpodoxime—Pruritus—Fluorouracil—urinary bladder cancer	0.000671	0.000675	CcSEcCtD
Cefpodoxime—Stevens-Johnson syndrome—Doxorubicin—urinary bladder cancer	0.000664	0.000668	CcSEcCtD
Cefpodoxime—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000663	0.000666	CcSEcCtD
Cefpodoxime—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00066	0.000664	CcSEcCtD
Cefpodoxime—Renal failure—Doxorubicin—urinary bladder cancer	0.000659	0.000662	CcSEcCtD
Cefpodoxime—Erythema multiforme—Methotrexate—urinary bladder cancer	0.000657	0.000661	CcSEcCtD
Cefpodoxime—Urticaria—Etoposide—urinary bladder cancer	0.000654	0.000658	CcSEcCtD
Cefpodoxime—Haemoglobin—Epirubicin—urinary bladder cancer	0.000653	0.000657	CcSEcCtD
Cefpodoxime—Stomatitis—Doxorubicin—urinary bladder cancer	0.000653	0.000657	CcSEcCtD
Cefpodoxime—Rhinitis—Epirubicin—urinary bladder cancer	0.000652	0.000655	CcSEcCtD
Cefpodoxime—Abdominal pain—Etoposide—urinary bladder cancer	0.000651	0.000655	CcSEcCtD
Cefpodoxime—Body temperature increased—Etoposide—urinary bladder cancer	0.000651	0.000655	CcSEcCtD
Cefpodoxime—Haemorrhage—Epirubicin—urinary bladder cancer	0.00065	0.000654	CcSEcCtD
Cefpodoxime—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000649	0.000653	CcSEcCtD
Cefpodoxime—Tinnitus—Methotrexate—urinary bladder cancer	0.000648	0.000651	CcSEcCtD
Cefpodoxime—Asthenia—Cisplatin—urinary bladder cancer	0.000645	0.000649	CcSEcCtD
Cefpodoxime—Oedema peripheral—Epirubicin—urinary bladder cancer	0.00064	0.000644	CcSEcCtD
Cefpodoxime—Haematuria—Doxorubicin—urinary bladder cancer	0.000639	0.000643	CcSEcCtD
Cefpodoxime—Epistaxis—Doxorubicin—urinary bladder cancer	0.000632	0.000636	CcSEcCtD
Cefpodoxime—Sinusitis—Doxorubicin—urinary bladder cancer	0.000629	0.000632	CcSEcCtD
Cefpodoxime—Dizziness—Fluorouracil—urinary bladder cancer	0.000627	0.000631	CcSEcCtD
Cefpodoxime—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000625	0.000629	CcSEcCtD
Cefpodoxime—Chills—Methotrexate—urinary bladder cancer	0.000623	0.000627	CcSEcCtD
Cefpodoxime—Diarrhoea—Cisplatin—urinary bladder cancer	0.000615	0.000619	CcSEcCtD
Cefpodoxime—Erythema multiforme—Epirubicin—urinary bladder cancer	0.000615	0.000618	CcSEcCtD
Cefpodoxime—Alopecia—Methotrexate—urinary bladder cancer	0.000614	0.000617	CcSEcCtD
Cefpodoxime—Vomiting—Gemcitabine—urinary bladder cancer	0.000613	0.000617	CcSEcCtD
Cefpodoxime—Rash—Gemcitabine—urinary bladder cancer	0.000608	0.000612	CcSEcCtD
Cefpodoxime—Dermatitis—Gemcitabine—urinary bladder cancer	0.000608	0.000611	CcSEcCtD
Cefpodoxime—Hypersensitivity—Etoposide—urinary bladder cancer	0.000607	0.00061	CcSEcCtD
Cefpodoxime—Tinnitus—Epirubicin—urinary bladder cancer	0.000606	0.00061	CcSEcCtD
Cefpodoxime—Haemoglobin—Doxorubicin—urinary bladder cancer	0.000604	0.000608	CcSEcCtD
Cefpodoxime—Headache—Gemcitabine—urinary bladder cancer	0.000604	0.000608	CcSEcCtD
Cefpodoxime—Vomiting—Fluorouracil—urinary bladder cancer	0.000603	0.000607	CcSEcCtD
Cefpodoxime—Rhinitis—Doxorubicin—urinary bladder cancer	0.000603	0.000606	CcSEcCtD
Cefpodoxime—Haemorrhage—Doxorubicin—urinary bladder cancer	0.000601	0.000605	CcSEcCtD
Cefpodoxime—Rash—Fluorouracil—urinary bladder cancer	0.000598	0.000602	CcSEcCtD
Cefpodoxime—Dermatitis—Fluorouracil—urinary bladder cancer	0.000598	0.000601	CcSEcCtD
Cefpodoxime—Headache—Fluorouracil—urinary bladder cancer	0.000594	0.000598	CcSEcCtD
Cefpodoxime—Oedema peripheral—Doxorubicin—urinary bladder cancer	0.000592	0.000596	CcSEcCtD
Cefpodoxime—Dysgeusia—Methotrexate—urinary bladder cancer	0.000592	0.000596	CcSEcCtD
Cefpodoxime—Asthenia—Etoposide—urinary bladder cancer	0.000591	0.000595	CcSEcCtD
Cefpodoxime—Back pain—Methotrexate—urinary bladder cancer	0.000585	0.000588	CcSEcCtD
Cefpodoxime—Chills—Epirubicin—urinary bladder cancer	0.000583	0.000587	CcSEcCtD
Cefpodoxime—Pruritus—Etoposide—urinary bladder cancer	0.000583	0.000586	CcSEcCtD
Cefpodoxime—Alopecia—Epirubicin—urinary bladder cancer	0.000574	0.000578	CcSEcCtD
Cefpodoxime—Nausea—Gemcitabine—urinary bladder cancer	0.000573	0.000576	CcSEcCtD
Cefpodoxime—Vomiting—Cisplatin—urinary bladder cancer	0.000572	0.000575	CcSEcCtD
Cefpodoxime—Erythema multiforme—Doxorubicin—urinary bladder cancer	0.000569	0.000572	CcSEcCtD
Cefpodoxime—Rash—Cisplatin—urinary bladder cancer	0.000567	0.00057	CcSEcCtD
Cefpodoxime—Dermatitis—Cisplatin—urinary bladder cancer	0.000566	0.00057	CcSEcCtD
Cefpodoxime—Diarrhoea—Etoposide—urinary bladder cancer	0.000564	0.000567	CcSEcCtD
Cefpodoxime—Nausea—Fluorouracil—urinary bladder cancer	0.000563	0.000567	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000561	0.000564	CcSEcCtD
Cefpodoxime—Tinnitus—Doxorubicin—urinary bladder cancer	0.000561	0.000564	CcSEcCtD
Cefpodoxime—Anaemia—Methotrexate—urinary bladder cancer	0.000559	0.000562	CcSEcCtD
Cefpodoxime—Flatulence—Epirubicin—urinary bladder cancer	0.000558	0.000561	CcSEcCtD
Cefpodoxime—Tension—Epirubicin—urinary bladder cancer	0.000555	0.000558	CcSEcCtD
Cefpodoxime—Dysgeusia—Epirubicin—urinary bladder cancer	0.000554	0.000557	CcSEcCtD
Cefpodoxime—Nervousness—Epirubicin—urinary bladder cancer	0.00055	0.000553	CcSEcCtD
Cefpodoxime—Back pain—Epirubicin—urinary bladder cancer	0.000547	0.000551	CcSEcCtD
Cefpodoxime—Malaise—Methotrexate—urinary bladder cancer	0.000545	0.000548	CcSEcCtD
Cefpodoxime—Dizziness—Etoposide—urinary bladder cancer	0.000545	0.000548	CcSEcCtD
Cefpodoxime—Vertigo—Methotrexate—urinary bladder cancer	0.000543	0.000546	CcSEcCtD
Cefpodoxime—Leukopenia—Methotrexate—urinary bladder cancer	0.000541	0.000544	CcSEcCtD
Cefpodoxime—Chills—Doxorubicin—urinary bladder cancer	0.00054	0.000543	CcSEcCtD
Cefpodoxime—Nausea—Cisplatin—urinary bladder cancer	0.000534	0.000537	CcSEcCtD
Cefpodoxime—Alopecia—Doxorubicin—urinary bladder cancer	0.000531	0.000535	CcSEcCtD
Cefpodoxime—Cough—Methotrexate—urinary bladder cancer	0.000528	0.000531	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.000525	0.000528	CcSEcCtD
Cefpodoxime—Convulsion—Methotrexate—urinary bladder cancer	0.000524	0.000527	CcSEcCtD
Cefpodoxime—Vomiting—Etoposide—urinary bladder cancer	0.000524	0.000527	CcSEcCtD
Cefpodoxime—Anaemia—Epirubicin—urinary bladder cancer	0.000523	0.000526	CcSEcCtD
Cefpodoxime—Agitation—Epirubicin—urinary bladder cancer	0.00052	0.000523	CcSEcCtD
Cefpodoxime—Rash—Etoposide—urinary bladder cancer	0.000519	0.000522	CcSEcCtD
Cefpodoxime—Dermatitis—Etoposide—urinary bladder cancer	0.000519	0.000522	CcSEcCtD
Cefpodoxime—Headache—Etoposide—urinary bladder cancer	0.000516	0.000519	CcSEcCtD
Cefpodoxime—Flatulence—Doxorubicin—urinary bladder cancer	0.000516	0.000519	CcSEcCtD
Cefpodoxime—Chest pain—Methotrexate—urinary bladder cancer	0.000515	0.000518	CcSEcCtD
Cefpodoxime—Myalgia—Methotrexate—urinary bladder cancer	0.000515	0.000518	CcSEcCtD
Cefpodoxime—Tension—Doxorubicin—urinary bladder cancer	0.000514	0.000517	CcSEcCtD
Cefpodoxime—Dysgeusia—Doxorubicin—urinary bladder cancer	0.000513	0.000516	CcSEcCtD
Cefpodoxime—Malaise—Epirubicin—urinary bladder cancer	0.00051	0.000513	CcSEcCtD
Cefpodoxime—Discomfort—Methotrexate—urinary bladder cancer	0.000509	0.000512	CcSEcCtD
Cefpodoxime—Nervousness—Doxorubicin—urinary bladder cancer	0.000508	0.000511	CcSEcCtD
Cefpodoxime—Vertigo—Epirubicin—urinary bladder cancer	0.000508	0.000511	CcSEcCtD
Cefpodoxime—Syncope—Epirubicin—urinary bladder cancer	0.000507	0.00051	CcSEcCtD
Cefpodoxime—Leukopenia—Epirubicin—urinary bladder cancer	0.000506	0.000509	CcSEcCtD
Cefpodoxime—Back pain—Doxorubicin—urinary bladder cancer	0.000506	0.000509	CcSEcCtD
Cefpodoxime—Palpitations—Epirubicin—urinary bladder cancer	0.0005	0.000503	CcSEcCtD
Cefpodoxime—Confusional state—Methotrexate—urinary bladder cancer	0.000498	0.0005	CcSEcCtD
Cefpodoxime—Loss of consciousness—Epirubicin—urinary bladder cancer	0.000497	0.0005	CcSEcCtD
Cefpodoxime—Cough—Epirubicin—urinary bladder cancer	0.000494	0.000497	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000493	0.000496	CcSEcCtD
Cefpodoxime—Convulsion—Epirubicin—urinary bladder cancer	0.00049	0.000493	CcSEcCtD
Cefpodoxime—Nausea—Etoposide—urinary bladder cancer	0.000489	0.000492	CcSEcCtD
Cefpodoxime—Hypertension—Epirubicin—urinary bladder cancer	0.000489	0.000491	CcSEcCtD
Cefpodoxime—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000486	0.000489	CcSEcCtD
Cefpodoxime—Anaemia—Doxorubicin—urinary bladder cancer	0.000484	0.000487	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000483	0.000486	CcSEcCtD
Cefpodoxime—Chest pain—Epirubicin—urinary bladder cancer	0.000482	0.000485	CcSEcCtD
Cefpodoxime—Myalgia—Epirubicin—urinary bladder cancer	0.000482	0.000485	CcSEcCtD
Cefpodoxime—Agitation—Doxorubicin—urinary bladder cancer	0.000481	0.000484	CcSEcCtD
Cefpodoxime—Anxiety—Epirubicin—urinary bladder cancer	0.00048	0.000483	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Methotrexate—urinary bladder cancer	0.000477	0.00048	CcSEcCtD
Cefpodoxime—Discomfort—Epirubicin—urinary bladder cancer	0.000476	0.000479	CcSEcCtD
Cefpodoxime—Malaise—Doxorubicin—urinary bladder cancer	0.000472	0.000475	CcSEcCtD
Cefpodoxime—Dry mouth—Epirubicin—urinary bladder cancer	0.000471	0.000474	CcSEcCtD
Cefpodoxime—Vertigo—Doxorubicin—urinary bladder cancer	0.00047	0.000473	CcSEcCtD
Cefpodoxime—Anorexia—Methotrexate—urinary bladder cancer	0.00047	0.000473	CcSEcCtD
Cefpodoxime—Syncope—Doxorubicin—urinary bladder cancer	0.000469	0.000472	CcSEcCtD
Cefpodoxime—Leukopenia—Doxorubicin—urinary bladder cancer	0.000469	0.000471	CcSEcCtD
Cefpodoxime—Confusional state—Epirubicin—urinary bladder cancer	0.000466	0.000468	CcSEcCtD
Cefpodoxime—Palpitations—Doxorubicin—urinary bladder cancer	0.000463	0.000465	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000462	0.000464	CcSEcCtD
Cefpodoxime—Hypotension—Methotrexate—urinary bladder cancer	0.000461	0.000464	CcSEcCtD
Cefpodoxime—Loss of consciousness—Doxorubicin—urinary bladder cancer	0.00046	0.000463	CcSEcCtD
Cefpodoxime—Cough—Doxorubicin—urinary bladder cancer	0.000457	0.00046	CcSEcCtD
Cefpodoxime—Shock—Epirubicin—urinary bladder cancer	0.000454	0.000457	CcSEcCtD
Cefpodoxime—Convulsion—Doxorubicin—urinary bladder cancer	0.000454	0.000456	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000452	0.000455	CcSEcCtD
Cefpodoxime—Hypertension—Doxorubicin—urinary bladder cancer	0.000452	0.000455	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00045	0.000452	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Epirubicin—urinary bladder cancer	0.000446	0.000449	CcSEcCtD
Cefpodoxime—Insomnia—Methotrexate—urinary bladder cancer	0.000446	0.000449	CcSEcCtD
Cefpodoxime—Chest pain—Doxorubicin—urinary bladder cancer	0.000446	0.000448	CcSEcCtD
Cefpodoxime—Myalgia—Doxorubicin—urinary bladder cancer	0.000446	0.000448	CcSEcCtD
Cefpodoxime—Anxiety—Doxorubicin—urinary bladder cancer	0.000444	0.000447	CcSEcCtD
Cefpodoxime—Paraesthesia—Methotrexate—urinary bladder cancer	0.000443	0.000446	CcSEcCtD
Cefpodoxime—Discomfort—Doxorubicin—urinary bladder cancer	0.00044	0.000443	CcSEcCtD
Cefpodoxime—Anorexia—Epirubicin—urinary bladder cancer	0.00044	0.000443	CcSEcCtD
Cefpodoxime—Dyspnoea—Methotrexate—urinary bladder cancer	0.00044	0.000443	CcSEcCtD
Cefpodoxime—Somnolence—Methotrexate—urinary bladder cancer	0.000439	0.000441	CcSEcCtD
Cefpodoxime—Dry mouth—Doxorubicin—urinary bladder cancer	0.000436	0.000438	CcSEcCtD
Cefpodoxime—Dyspepsia—Methotrexate—urinary bladder cancer	0.000434	0.000437	CcSEcCtD
Cefpodoxime—Hypotension—Epirubicin—urinary bladder cancer	0.000431	0.000434	CcSEcCtD
Cefpodoxime—Confusional state—Doxorubicin—urinary bladder cancer	0.000431	0.000433	CcSEcCtD
Cefpodoxime—Decreased appetite—Methotrexate—urinary bladder cancer	0.000429	0.000431	CcSEcCtD
Cefpodoxime—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.000427	0.00043	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.000426	0.000429	CcSEcCtD
Cefpodoxime—Fatigue—Methotrexate—urinary bladder cancer	0.000425	0.000428	CcSEcCtD
Cefpodoxime—Pain—Methotrexate—urinary bladder cancer	0.000422	0.000424	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000421	0.000423	CcSEcCtD
Cefpodoxime—Shock—Doxorubicin—urinary bladder cancer	0.00042	0.000423	CcSEcCtD
Cefpodoxime—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000418	0.000421	CcSEcCtD
Cefpodoxime—Insomnia—Epirubicin—urinary bladder cancer	0.000418	0.00042	CcSEcCtD
Cefpodoxime—Paraesthesia—Epirubicin—urinary bladder cancer	0.000415	0.000417	CcSEcCtD
Cefpodoxime—Hyperhidrosis—Doxorubicin—urinary bladder cancer	0.000413	0.000415	CcSEcCtD
Cefpodoxime—Dyspnoea—Epirubicin—urinary bladder cancer	0.000412	0.000414	CcSEcCtD
Cefpodoxime—Somnolence—Epirubicin—urinary bladder cancer	0.000411	0.000413	CcSEcCtD
Cefpodoxime—Anorexia—Doxorubicin—urinary bladder cancer	0.000407	0.00041	CcSEcCtD
Cefpodoxime—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000407	0.000409	CcSEcCtD
Cefpodoxime—Dyspepsia—Epirubicin—urinary bladder cancer	0.000406	0.000409	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000403	0.000406	CcSEcCtD
Cefpodoxime—Decreased appetite—Epirubicin—urinary bladder cancer	0.000401	0.000404	CcSEcCtD
Cefpodoxime—Hypotension—Doxorubicin—urinary bladder cancer	0.000399	0.000402	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000399	0.000401	CcSEcCtD
Cefpodoxime—Fatigue—Epirubicin—urinary bladder cancer	0.000398	0.0004	CcSEcCtD
Cefpodoxime—Constipation—Epirubicin—urinary bladder cancer	0.000395	0.000397	CcSEcCtD
Cefpodoxime—Pain—Epirubicin—urinary bladder cancer	0.000395	0.000397	CcSEcCtD
Cefpodoxime—Urticaria—Methotrexate—urinary bladder cancer	0.000392	0.000394	CcSEcCtD
Cefpodoxime—Abdominal pain—Methotrexate—urinary bladder cancer	0.00039	0.000392	CcSEcCtD
Cefpodoxime—Body temperature increased—Methotrexate—urinary bladder cancer	0.00039	0.000392	CcSEcCtD
Cefpodoxime—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000389	0.000392	CcSEcCtD
Cefpodoxime—Insomnia—Doxorubicin—urinary bladder cancer	0.000386	0.000389	CcSEcCtD
Cefpodoxime—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000384	0.000386	CcSEcCtD
Cefpodoxime—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000381	0.000383	CcSEcCtD
Cefpodoxime—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000381	0.000383	CcSEcCtD
Cefpodoxime—Somnolence—Doxorubicin—urinary bladder cancer	0.00038	0.000382	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000378	0.00038	CcSEcCtD
Cefpodoxime—Dyspepsia—Doxorubicin—urinary bladder cancer	0.000376	0.000378	CcSEcCtD
Cefpodoxime—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000371	0.000374	CcSEcCtD
Cefpodoxime—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000369	0.000371	CcSEcCtD
Cefpodoxime—Fatigue—Doxorubicin—urinary bladder cancer	0.000368	0.000371	CcSEcCtD
Cefpodoxime—Urticaria—Epirubicin—urinary bladder cancer	0.000367	0.000369	CcSEcCtD
Cefpodoxime—Pain—Doxorubicin—urinary bladder cancer	0.000365	0.000368	CcSEcCtD
Cefpodoxime—Constipation—Doxorubicin—urinary bladder cancer	0.000365	0.000368	CcSEcCtD
Cefpodoxime—Body temperature increased—Epirubicin—urinary bladder cancer	0.000365	0.000367	CcSEcCtD
Cefpodoxime—Abdominal pain—Epirubicin—urinary bladder cancer	0.000365	0.000367	CcSEcCtD
Cefpodoxime—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000364	0.000366	CcSEcCtD
Cefpodoxime—Asthenia—Methotrexate—urinary bladder cancer	0.000354	0.000356	CcSEcCtD
Cefpodoxime—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000352	0.000354	CcSEcCtD
Cefpodoxime—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000349	0.000351	CcSEcCtD
Cefpodoxime—Pruritus—Methotrexate—urinary bladder cancer	0.000349	0.000351	CcSEcCtD
Cefpodoxime—Hypersensitivity—Epirubicin—urinary bladder cancer	0.00034	0.000342	CcSEcCtD
Cefpodoxime—Urticaria—Doxorubicin—urinary bladder cancer	0.000339	0.000341	CcSEcCtD
Cefpodoxime—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000338	0.00034	CcSEcCtD
Cefpodoxime—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000338	0.00034	CcSEcCtD
Cefpodoxime—Diarrhoea—Methotrexate—urinary bladder cancer	0.000338	0.00034	CcSEcCtD
Cefpodoxime—Asthenia—Epirubicin—urinary bladder cancer	0.000331	0.000333	CcSEcCtD
Cefpodoxime—Pruritus—Epirubicin—urinary bladder cancer	0.000327	0.000329	CcSEcCtD
Cefpodoxime—Dizziness—Methotrexate—urinary bladder cancer	0.000326	0.000328	CcSEcCtD
Cefpodoxime—Diarrhoea—Epirubicin—urinary bladder cancer	0.000316	0.000318	CcSEcCtD
Cefpodoxime—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000315	0.000317	CcSEcCtD
Cefpodoxime—Vomiting—Methotrexate—urinary bladder cancer	0.000314	0.000316	CcSEcCtD
Cefpodoxime—Rash—Methotrexate—urinary bladder cancer	0.000311	0.000313	CcSEcCtD
Cefpodoxime—Dermatitis—Methotrexate—urinary bladder cancer	0.000311	0.000313	CcSEcCtD
Cefpodoxime—Headache—Methotrexate—urinary bladder cancer	0.000309	0.000311	CcSEcCtD
Cefpodoxime—Asthenia—Doxorubicin—urinary bladder cancer	0.000307	0.000308	CcSEcCtD
Cefpodoxime—Dizziness—Epirubicin—urinary bladder cancer	0.000305	0.000307	CcSEcCtD
Cefpodoxime—Pruritus—Doxorubicin—urinary bladder cancer	0.000302	0.000304	CcSEcCtD
Cefpodoxime—Vomiting—Epirubicin—urinary bladder cancer	0.000294	0.000295	CcSEcCtD
Cefpodoxime—Nausea—Methotrexate—urinary bladder cancer	0.000293	0.000295	CcSEcCtD
Cefpodoxime—Diarrhoea—Doxorubicin—urinary bladder cancer	0.000292	0.000294	CcSEcCtD
Cefpodoxime—Rash—Epirubicin—urinary bladder cancer	0.000291	0.000293	CcSEcCtD
Cefpodoxime—Dermatitis—Epirubicin—urinary bladder cancer	0.000291	0.000293	CcSEcCtD
Cefpodoxime—Headache—Epirubicin—urinary bladder cancer	0.000289	0.000291	CcSEcCtD
Cefpodoxime—Dizziness—Doxorubicin—urinary bladder cancer	0.000283	0.000284	CcSEcCtD
Cefpodoxime—Nausea—Epirubicin—urinary bladder cancer	0.000274	0.000276	CcSEcCtD
Cefpodoxime—Vomiting—Doxorubicin—urinary bladder cancer	0.000272	0.000273	CcSEcCtD
Cefpodoxime—Rash—Doxorubicin—urinary bladder cancer	0.000269	0.000271	CcSEcCtD
Cefpodoxime—Dermatitis—Doxorubicin—urinary bladder cancer	0.000269	0.000271	CcSEcCtD
Cefpodoxime—Headache—Doxorubicin—urinary bladder cancer	0.000268	0.000269	CcSEcCtD
Cefpodoxime—Nausea—Doxorubicin—urinary bladder cancer	0.000254	0.000255	CcSEcCtD
